These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 38281991)

  • 1. Current status of stem cell therapy for type 1 diabetes: a critique and a prospective consideration.
    Ghoneim MA; Gabr MM; El-Halawani SM; Refaie AF
    Stem Cell Res Ther; 2024 Jan; 15(1):23. PubMed ID: 38281991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From Mesenchymal Stromal/Stem Cells to Insulin-Producing Cells: Immunological Considerations.
    Refaie AF; Elbassiouny BL; Kloc M; Sabek OM; Khater SM; Ismail AM; Mohamed RH; Ghoneim MA
    Front Immunol; 2021; 12():690623. PubMed ID: 34248981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipose tissue-derived mesenchymal stromal cells efficiently differentiate into insulin-producing cells in pancreatic islet microenvironment both in vitro and in vivo.
    Karaoz E; Okcu A; Ünal ZS; Subasi C; Saglam O; Duruksu G
    Cytotherapy; 2013 May; 15(5):557-70. PubMed ID: 23388582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of marginal mass required for successful islet transplantation in a diabetic rat model using adipose tissue-derived mesenchymal stromal cells.
    Navaei-Nigjeh M; Moloudizargari M; Baeeri M; Gholami M; Lotfibakhshaiesh N; Soleimani M; Vasheghani-Farahani E; Ai J; Abdollahi M
    Cytotherapy; 2018 Sep; 20(9):1124-1142. PubMed ID: 30068495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do we really need to differentiate mesenchymal stem cells into insulin-producing cells for attenuation of the autoimmune responses in type 1 diabetes: immunoprophylactic effects of precursors to insulin-producing cells.
    Sharma A; Rani R
    Stem Cell Res Ther; 2017 Jul; 8(1):167. PubMed ID: 28701182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes.
    Vija L; Farge D; Gautier JF; Vexiau P; Dumitrache C; Bourgarit A; Verrecchia F; Larghero J
    Diabetes Metab; 2009 Apr; 35(2):85-93. PubMed ID: 19230736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ectopic expression of insulin in a type 1 diabetic rat model by injection of manipulated mesenchymal stem cells with an insulin construct driven by a glucose-sensitive promoter in the port vein.
    Mohammad Dezashibi H; Farzad-Mohajeri S; Bandehpour M; Shabani A; Kazemi B
    Cell Biochem Funct; 2023 Dec; 41(8):1412-1421. PubMed ID: 37877623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation of insulin-producing cells derived from human mesenchymal stromal/stem cells into diabetic humanized mice.
    Ghoneim MA; Gabr MM; Refaie AF; El-Halawani SM; Al-Issawi MM; Elbassiouny BL; Kader MAAE; Ismail AM; Zidan MF; Karras MS; Magar RW; Khater SM; Ashamallah SA; Zakaria MM; Kloc M
    Stem Cell Res Ther; 2022 Jul; 13(1):350. PubMed ID: 35883190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells and differentiated insulin producing cells are new horizons for pancreatic regeneration in type I diabetes mellitus.
    Domouky AM; Hegab AS; Al-Shahat A; Raafat N
    Int J Biochem Cell Biol; 2017 Jun; 87():77-85. PubMed ID: 28385600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Undifferentiated Wharton's Jelly Mesenchymal Stem Cell Transplantation Induces Insulin-Producing Cell Differentiation and Suppression of T-Cell-Mediated Autoimmunity in Nonobese Diabetic Mice.
    Tsai PJ; Wang HS; Lin GJ; Chou SC; Chu TH; Chuan WT; Lu YJ; Weng ZC; Su CH; Hsieh PS; Sytwu HK; Lin CH; Chen TH; Shyu JF
    Cell Transplant; 2015; 24(8):1555-70. PubMed ID: 25198179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From Mesenchymal Stromal/Stem Cells to Insulin-Producing Cells: Progress and Challenges.
    Ghoneim MA; Refaie AF; Elbassiouny BL; Gabr MM; Zakaria MM
    Stem Cell Rev Rep; 2020 Dec; 16(6):1156-1172. PubMed ID: 32880857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro Generated Mesenchymal Stem Cells: Suitable Tools to Target Insulin Dependent Diabetes Mellitus?
    Dave SD; Patel CN; Patel JV; Thakkar UG
    Curr Stem Cell Res Ther; 2017; 12(4):288-299. PubMed ID: 27903221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal Stem Cells: Rising Concerns over Their Application in Treatment of Type One Diabetes Mellitus.
    Hashemian SJ; Kouhnavard M; Nasli-Esfahani E
    J Diabetes Res; 2015; 2015():675103. PubMed ID: 26576437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic diabetic mesenchymal stem cells transplantation in streptozotocin-induced diabetic rat.
    Dong QY; Chen L; Gao GQ; Wang L; Song J; Chen B; Xu YX; Sun L
    Clin Invest Med; 2008 Dec; 31(6):E328-37. PubMed ID: 19032902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of insulin-producing cells differentiated from tonsil derived mesenchymal stem cells.
    Kim SY; Kim YR; Park WJ; Kim HS; Jung SC; Woo SY; Jo I; Ryu KH; Park JW
    Differentiation; 2015; 90(1-3):27-39. PubMed ID: 26391447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of insulin-producing cells from human bone marrow mesenchymal stem cells by genetic manipulation.
    Karnieli O; Izhar-Prato Y; Bulvik S; Efrat S
    Stem Cells; 2007 Nov; 25(11):2837-44. PubMed ID: 17615265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells in the treatment of type 1 diabetes mellitus.
    Katuchova J; Harvanova D; Spakova T; Kalanin R; Farkas D; Durny P; Rosocha J; Radonak J; Petrovic D; Siniscalco D; Qi M; Novak M; Kruzliak P
    Endocr Pathol; 2015 May; 26(2):95-103. PubMed ID: 25762503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-producing cells from adult human bone marrow mesenchymal stem cells control streptozotocin-induced diabetes in nude mice.
    Gabr MM; Zakaria MM; Refaie AF; Ismail AM; Abou-El-Mahasen MA; Ashamallah SA; Khater SM; El-Halawani SM; Ibrahim RY; Uin GS; Kloc M; Calne RY; Ghoneim MA
    Cell Transplant; 2013; 22(1):133-45. PubMed ID: 22710060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cell-based therapy for the treatment of type 1 diabetes mellitus.
    Mabed M; Shahin M
    Curr Stem Cell Res Ther; 2012 May; 7(3):179-90. PubMed ID: 22023626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation of insulin-producing cells derived from umbilical cord stromal mesenchymal stem cells to treat NOD mice.
    Wang HS; Shyu JF; Shen WS; Hsu HC; Chi TC; Chen CP; Huang SW; Shyr YM; Tang KT; Chen TH
    Cell Transplant; 2011; 20(3):455-66. PubMed ID: 20719086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.